AKTEPE, O. H. Et Al. 2021. The platelet to lymphocyte ratio predicts overall survival better than the neutrophil to lymphocyte ratio in metastatic renal cell carcinoma. Turkish Journal of Medical Sciences , vol.51, no.2 , 757-765.

AKTEPE, O. H., Güner, G., GÜVEN, D. C., Şahın, T. K., Ardiç, F. S., Yüce, D., ... YALÇIN, Ş.(2021). The platelet to lymphocyte ratio predicts overall survival better than the neutrophil to lymphocyte ratio in metastatic renal cell carcinoma. Turkish Journal of Medical Sciences , vol.51, no.2, 757-765.

AKTEPE, OKTAY Et Al. "The platelet to lymphocyte ratio predicts overall survival better than the neutrophil to lymphocyte ratio in metastatic renal cell carcinoma," Turkish Journal of Medical Sciences , vol.51, no.2, 757-765, 2021

AKTEPE, OKTAY H. Et Al. "The platelet to lymphocyte ratio predicts overall survival better than the neutrophil to lymphocyte ratio in metastatic renal cell carcinoma." Turkish Journal of Medical Sciences , vol.51, no.2, pp.757-765, 2021

AKTEPE, O. H. Et Al. (2021) . "The platelet to lymphocyte ratio predicts overall survival better than the neutrophil to lymphocyte ratio in metastatic renal cell carcinoma." Turkish Journal of Medical Sciences , vol.51, no.2, pp.757-765.

@article{article, author={OKTAY HALİT AKTEPE Et Al. }, title={The platelet to lymphocyte ratio predicts overall survival better than the neutrophil to lymphocyte ratio in metastatic renal cell carcinoma}, journal={Turkish Journal of Medical Sciences}, year=2021, pages={757-765} }